Universal reference book for medicines
Product name: TADIMAX (TADIMAX)

Active substance: nonappropriate

Type: Phytomedication used for functional disorders of urination associated with benign prostatic hyperplasia

Manufacturer: DANAPHA PHARMACEUTICAL (Vietnam)
Composition, form of production and packaging
The tablets covered with a film membrane of
brown color, biconvex, oval, with a facet;
the nucleus is brown, on a brown cut with numerous small yellow patches.
1 tab.

dense aqueous extract from a mixture of herbal medicinal raw materials (14.5: 1):

Leaf Crinum 2 g

Anemarenes rhizomes 0.666 g

Velvet bark 0.666 g

Motherwort of grass 0.666 grams

Peach seed 0.083 g

Alismatis rhizomes 0.83 g

Peony roots 0.5 g

Bark cortex 0.0083 g

[PRING] silicon colloidal dioxide 0.055 g, starch 0.22 g, magnesium stearate 0.0065 g, hypromellose 0.007 g, talc 0.007 g, titanium dioxide 0.001 g, macrogol 6000 0.0015 g, ferric oxide red (E172) 0.0003 g, iron oxide black (E172 ) 0.0004 g.

21 pcs.
- blisters aluminum (2) - packs cardboard.
21 pcs.
- blisters aluminum (3) - packs cardboard.
INSTRUCTION FOR THE SPECIALIST.

Description of the drug approved by the manufacturer for the printed edition of 2014.

PHARMACHOLOGIC EFFECT

The drug has anti-inflammatory, analgesic, moderate angioprotective action.

INDICATIONS

- in complex therapy to eliminate dysuric disorders, with benign prostatic hyperplasia I and II stages.

DOSING MODE

Inside, 2 tablets 3 times a day after meals.
The drug should be taken according to the following scheme: 3 courses of 7 days of intake with breaks between courses of 7 days. The duration of treatment is determined by the doctor.
SIDE EFFECT

Allergic reactions are possible.
In 5% of cases at the beginning of the drug in patients, a burning sensation in the anus can occur. This phenomenon occurs in the process of taking the drug.
CONTRAINDICATIONS

- hypersensitivity to the components of the drug;

severe hepatic impairment.

PREGNANCY AND LACTATION

The use of the drug in women is not provided.

APPLICATION FOR VIOLATIONS OF THE FUNCTION OF KIDNEYS

Contraindicated in severe violations of liver function.

SPECIAL INSTRUCTIONS

Impact on the ability to drive vehicles and manage mechanisms

The drug does not affect the ability to drive vehicles and engage in other potentially hazardous activities that require increased concentration and speed of psychomotor reactions.

OVERDOSE

There were no cases of drug overdose Tadimaks.

DRUG INTERACTION

Not described.

TERMS OF RELEASE FROM PHARMACY

On prescription.

TERMS AND CONDITIONS OF STORAGE

In a dry, dark place at a temperature of 15 to 25 ° C.
Keep out of the reach of children! Shelf life - 3 years.
Alphabetical index of medicines:
A  B  V  G  D  E  J
Z  I  Y  K  L  M  N
O  P  R  S  T  U  F
H  C  CH  SH  E  U  Y
Rambler's Top100
Privacy policy:
Copyright 2009 - 2017. Universal reference book of medicines. All rights reserved.
When using site materials, an active hyperlink is required!